• Svitlana Pochepnia, Irene M Lang, Ruxandra Iulia Milos, Sebastian Röhrich, Ahmed Ba-Ssalamah, Lucian Beer, and Helmut Prosch.
• Vienna General Hospital, Dept. of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Währingergürtel 18-20, 1090, Vienna, Austria. svitlana.pochepnia@meduniwien.ac.at.
• Wien. Klin. Wochenschr. 2024 Feb 1; 136 (3-4): 118121118-121.

AbstractHughes-Stovin syndrome (HSS) is a rare vasculitis of unknown etiology. The disease is characterized by pronounced inflammation and damage to the vessel walls, with subsequent widespread vascular thrombosis and the formation of pulmonary artery aneurysms that can lead to fatal hemoptysis. This disorder can be mistaken for other conditions, such as chronic thromboembolic pulmonary disease (CTEPD) without or with pulmonary hypertension at rest (CTEPH).We report the case of a 20-year-old female with HSS, which was misdiagnosed as CTEPH and subsequently treated with anticoagulants, which led to severe hemoptysis and eventually death of the patient. This case highlights the challenges of diagnosing HSS at early stages of the disease.HSS should be considered in young patients with signs of large vessel vasculitis in combination with thrombotic occlusions of pulmonary arteries, with or without aneurysms of the pulmonary arteries, and particularly, if there are no risk factors for thromboembolic disease.© 2023. The Author(s).

26 keywords...

hide…